| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MOBQ | Common Stock | Exercise of in-the-money or at-the-money derivative security | $210,000 | +420,000 | +5.1% | $0.5000 | 8,643,695 | 30 Dec 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MOBQ | Convertible notes | Exercise of in-the-money or at-the-money derivative security | -210,000 | -34% | 411,544 | 30 Dec 2024 | Common Stock | 420,000 | $0.5000 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | Not applicable. |
| F2 | The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust. |
| F3 | Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share. |